keyboard_backspace Back

Septic Shock – beyond antibiotics, fluids and inotropes – is there benefit from ECMO or novel therapies?

The care of sepsis patients is largely unchanged for many years

The lecture duration is 51min.

1 CPD Point, 1 CEU.
Accredited by CPDUK and CBRN.

You can watch this lecture for free! For premium features, including a CPD/CME accredited certificate or to use time-coded note taking, you will need a fair price subscription.

Sign In or Sign Up For Free to access this lecture.
Steve McGloughlin
Director of Intensive Care, The Alfred Hospital, Australia
Lecture Summary

Despite the advances of modern critical care, there is remarkably little that has been demonstrated to change the trajectory of septic shock. We still rely on early recognition, good supportive care and appropriate antimicrobials to help these patients. This talk will focus on why these therapies are still the mainstays and how we need to work hard to ensure that in the near future – novel therapies and complex supportive care mechanisms such as ECMO can help the sickest patients.

NB.

This Free lectures comes with all premium features (note-taking, certification, etc) courtesy of ASN & CSL Behring

Target Audience

Healthcare Professionals that care for septic patients

Learning Objectives:

Upon completion of this activity, you should be able to:

  • Demonstrate why preventing the deterioration from sepsis to septic shock is the key to good patient outcomes
  • Summarise current best practice for the support of a patient with profound septic shock
  • Review the evidence for novel methods of critical care support for patients with septic shock including ECMO
  • Review the potential use of ECMO in Sepsis management

None.